CTI Life Sciences
VC · Montreal (Canada)
Sign up free to access full profile and submit your pitch.
About
CTI Life Sciences is a venture capital arm of CTI BioPharma Corp., specializing in series C, seed/startup, early venture and mid venture. It invests in the pre-clinical to proof-of-concept and secondarily on proof-of-concept to Phase III stages in pharmaceutical development process. The firm seeks to invest in the life sciences sector with a focus on biotechnology, medical technology, biopharmaceuticals, drugs, drug enabling technology, and medical devices. It prefers to invest in companies based in North America with a focus on the United States and Canada specifically in Quebec and Europe. Within pre-clinical to proof-of-concept stage, the firm invests between $5 million to $15 million in the first round with pre-money between $10 million and $20 million and post-money between $15 million and $35 million with a bump up of approximately two to three times. Within proof-of-concept to Phase III stage the firm invests between $25 million to $50 million in the first round with pre-money from $50 million to more than $100 million and post-money between $75 million and $150 million with a bump-up of approximately three to five times. It seeks to exit its investments through mergers and acquisitions. CTI Life Sciences was founded in 2006 and is based in Montreal, Canada.
Visit website ↗Investment Criteria
Sign up free to see full investment criteria and submit your pitch.
